Kinaxis Inc
NOTICIAS

Kinaxis Named a Customers’ Choice in Gartner ® Voice of the Customer for Supply Chain Planning Solutions 2024

Kinaxis Inc. (TSX: KXS), a leader in end-to-end supply chain orchestration, has been recognized as a Customer’s Choice for Supply Chain Planning Solutions in the 2024 Gartner® Peer Insights™ report. Kinaxis surpassed the market average for overall experience, user interest, and adoption. Key scores include 4.8/5 for product capabilities, 4.5 for customer service, and 4.6 for overall user experience, with 93% of customers recommending Kinaxis.

Kirby McInerney LLP
NOTICIAS

Kirby McInerney LLP Reminds AMMO Incorporated (POWW) Investors of Class Action Lawsuit and Encourages Investors to Contact the Firm

Kirby McInerney LLP alerts investors to a class action lawsuit filed against AMMO Incorporated (NASDAQ: POWW) in the U.S. District Court for the District of Arizona. The lawsuit covers the period from August 19, 2020, to September 24, 2024, alleging issues with the company’s financial reporting and internal controls. Investors must apply for lead plaintiff status by November 29, 2024. The case stems from AMMO’s disclosure of its CFO’s resignation and an independent investigation into financial reporting errors, causing a 5.26% stock drop.

HTEC
NOTICIAS

MetConnections partners with HTEC to develop an innovative AI-powered connection application

HTEC, a global digital engineering services company, has partnered with MetConnections, an AI-driven app platform designed to promote spontaneous face-to-face interactions through personalized match suggestions. HTEC’s engineering, product, and design teams are collaborating with MetConnections to ensure platform reliability and security, leveraging HTEC’s StepFrame AI framework for efficient development. The partnership aims to create a transformative tool for fostering meaningful real-world connections, whether for professional networking or social engagement.

Acadia Pharmaceuticals Inc
NOTICIAS

Acadia Pharmaceuticals to Announce Third Quarter Financial Results on November 6, 2024

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) will release its Q3 2024 financial results on November 6, 2024, after U.S. market close. A conference call and webcast will follow at 4:30 p.m. ET to discuss the results and operations. Participants can register online for call access, and a replay will be available on Acadia’s website until December 6, 2024. Acadia focuses on innovative neuroscience solutions, including FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome, with ongoing developments targeting Prader-Willi syndrome, Alzheimer’s psychosis, and other CNS disorders.

Helfie
SALUD

Helfie AI Appoints Healthcare Leaders Antonin de Fougerolles and Cheryl Buxton to Board of Directors

Helfie AI, an AI-powered mobile health platform, has appointed Dr. Tony de Fougerolles as Non-Executive Chairman and Cheryl Buxton as an independent board member. Dr. de Fougerolles brings extensive expertise in drug development and scaling startups, while Buxton offers global healthcare leadership experience. Helfie AI aims to revolutionize preventive healthcare by providing smartphone-based health screenings to billions worldwide. The platform enhances access, affordability, and equity in healthcare, addressing conditions like cardiovascular issues and skin health with user-controlled data.

Suscribirse al boletín informativo

Email Subscription Form

Copyright © Todas las marcas son propiedad de la respectiva empresa o de BORGES MEDIA INC. Queda prohibida la reproducción total o parcial de cualquiera de los contenidos que aquí aparecen, así como su traducción a cualquier idioma sin autorización escrita de su propietario, la mejor revista de Sacramento. Consulte nuestra  Política de Privacidad.